Shares of Merck & Co. Inc. MRK inched 0.74% higher to $102.00 Friday, on what proved to be an all-around mixed trading ...

Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

Bicycle Therapeutics plc (NASDAQ:BCYC) announced that it presented data showing the enhanced anti-tumor activity of ...

Chinese biotech firms are emerging in a highly resource-intensive and time-consuming scientific innovation endeavor drug discovery One of the latest ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

Profiles of the leading market vendors, including F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Co., Novartis ...

Top Players Command Over 70% of the CRISPR Market; Products Segment to Gain $4 Billion in Revenues by 2028 CRISPR and Cas ...

India], December 13: Merck Foundation, the philanthropic arm of Merck KGaA Germany, in partnership with the African First Ladies, announced the winners of Merck Foundation's SONG Awards 2023 under two ...

Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...